Antibacterial role for natural killer cells in host defense to Bacillus anthracis

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 234-242

  Gonzales, Christine M ^a   Williams, Courtney B ^a   Calderon, Veronica E ^a   Huante, Matthew B ^a   Moen, Scott T ^a   Popov, Vsevolod L ^a   Baze, Wallace B ^c   Peterson, Johnny W ^a,b   Endsley, Janice J ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTEREMIA; BACTERIAL LOAD; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; EDEMA; FEMALE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; T LYMPHOCYTE ACTIVATION; ADULT; ANIMAL; BACTERIAL SPORE; CELL CULTURE; DISEASE MODEL; DRUG ANTAGONISM; IMMUNOLOGY; LEUKAPHERESIS; MICROBIOLOGY; MIDDLE AGED;

ADULT; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEUKOCYTE REDUCTION PROCEDURES; MICE; MIDDLE AGED; SPORES, BACTERIAL; SURVIVAL ANALYSIS;

EID: 84857069679     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05439-11     Document Type: Article

References (29)

1. Ashkar AA, Reid S, Verdu EF, Zhang K, Coombes BK. 2009. Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues. Infect. Immun. 77:214 -222.
2. Baldari CT, Tonello F, Paccani SR, Montecucco C. 2006. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 27:434-440.
3. Bell DM, Kozarsky PE, Stephens DS. 2002. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg. Infect. Dis. 8:222-225.
4. Brill KJ, et al. 2001. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect. Immun. 69:1755-1765.
5. Comer JE, Chopra AK, Peterson JW, Konig R. 2005. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect. Immun. 73:8275-8281.
6. Comer JE, et al. 2006. Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin. Microb. Pathog. 41:96 -110.
7. Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J. Immunol. 176:7557-7565.
8. Cybulski RJ, Jr, Sanz P, O'Brien AD. 2009. Anthrax vaccination strategies. Mol. Aspects Med. 30:490 -502.
9. Endsley JJ, Endsley MA, Estes DM. 2006. Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. J. Leukoc. Biol. 79:71-79.
10. Endsley JJ, et al. 2009. Comparative antimicrobial activity of granulysin against bacterial biothreat agents. Open Microbiol. J. 3:92-96.
11. Esin S, et al. 2008. Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect. Immun. 76:1719 -1727.
12. Ferlazzo G, et al. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:1455-1462.
13. Fukao T. 2004. Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. Lancet Infect. Dis. 4:166 -170.
14. Garcia-Penarrubia P, Koster FT, Kelley RO, McDowell TD, Bankhurst AD. 1989. Antibacterial activity of human natural killer cells. J. Exp. Med. 169:99 -113.
15. Glomski IJ, et al. 2007. Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell. Microbiol. 9:502-513.
16. Godshall CJ, Scott MJ, Burch PT, Peyton JC, Cheadle WG. 2003. Natural killer cells participate in bacterial clearance during septic peritonitis through interactions with macrophages. Shock 19:144 -149.
17. Harshan KV, Gangadharam PR. 1991. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect. Immun. 59:2818 -2821.
18. Hogg AE, Bowick GC, Herzog NK, Cloyd MW, Endsley JJ. 2009. Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1. J. Leukoc. Biol. 86:1191-1203.
19. Hu H, Emerson J, Aronson AI. 2007. Factors involved in the germination and inactivation of Bacillus anthracis spores in murine primary macrophages. FEMS Microbiol. Lett. 272:245-250.
20. Joshi SK, et al. 2009. Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy. PLoS Pathog. 5:e1000588.
21. Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L. 2008. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15:226 -233.
22. Peterson JW, et al. 2007. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Infect. Immun. 75:3414 -3424.
23. Peterson JW, et al. 2006. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Infect. Immun. 74:1016 -1024.
24. Shegarfi H, et al. 2009. The role of natural killer cells in resistance to the intracellular bacterium Listeria monocytogenes in rats. Scand. J. Immunol. 70:238 -244.
25. Stenger S, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125.
26. Troyer RM, Propst KL, Fairman J, Bosio CM, Dow SW. 2009. Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis. Vaccine 27:4424-4433.
27. Vahlne G, Becker S, Brodin P, Johansson MH. 2008. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand. J. Immunol. 67:1-11.
28. Vivier E, Nunes JA, Vely F. 2004. Natural killer cell signaling pathways. Science 306:1517-1519.
29. Yoneda T, Ellner JJ. 1998. CD4(+) T cell and natural killer celldependent killing of Mycobacterium tuberculosis by human monocytes. Am. J. Respir. Crit. Care Med. 158:395- 403.